Product Description

Livonibe 200mg Tablet consists of the active ingredient Sorafenib that is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients ineligible for surgery and differentiated thyroid carcinoma (thyroid cancer) in patients who are not responsive to radioactive iodine therapy.

Vascular endothelial growth factor (VEGF) interacts with its receptor to generate angiogenesis, which ultimately facilitates the growth and spread of cancer. This medicine acts against the overexpression of these receptors that is common in several types of cancer.

How to use

Take the tablet without food (1 hour before or 2 hours after meal). Swallow with a glass of water.

Uses

Treatment of Cancer
Treatment of Kidney (renal) cancer
Treatment of Thyroid cancer

Side Effects

Serious:

• Stevens Johnsons Syndrome and toxic epidermal necrosis
• Decreased blood flow to the heart
• Increased risk of bleeding (blood in urine, stool, vomit, cough, etc)
• High BP
• Skin problems
• Liver problems
• Problems in wound healing

Common:

• Nausea, stomach pain, diarrhea
• Tiredness and weakness
• Infection
• Hair thinning and patchy hair loss
• Rash
• Weight loss
• Loss of appetite
• Low levels of calcium in the blood

Storage

Store below 30℃